Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and activates autophagy

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3547-3554

  Mealer, Robert G ^a   Murray, Alexandra J ^a   Shahani, Neelam ^d   Subramaniam, Srinivasa ^d   Snyder, Solomon H ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pharmacology and Molecular Sciences ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY; BCL-2; BECLIN-1; HUNTINGTON DISEASE; MTOR; NEURODEGENERATIVE DISEASES; RHES;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; GENE DELETION; GTP-BINDING PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; HUNTINGTON DISEASE; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; PC12 CELLS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84893690813     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.536912     Document Type: Article

References (44)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983
2. Ross, C. A., and Tabrizi, S. J. (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83-98
3. Li, S. H., Schilling, G., Young, W. S., 3rd, Li, X. J., Margolis, R. L., Stine, O. C., Wagster, M. V., Abbott, M. H., Franz, M. L., and Ranen, N. G. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993
4. Subramaniam, S., Sixt, K. M., Barrow, R., and Snyder, S. H. (2009) Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330
5. Mealer, R. G., and Snyder, S. H. (2012) Rhes is a striatal-enriched protein with pathophysiologic relevance. Eur. J. Neurodegen. Dis. 1, 89-100
6. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., Illes, K., Lukacsovich, T., Zhu, Y. Z., Cattaneo, E., Pandolfi, P. P., Thompson, L. M., and Marsh, J. L. (2004) SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104
7. Subramaniam, S., Mealer, R. G., Sixt, K. M., Barrow, R. K., Usiello, A., and Snyder, S. H. (2010) Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. J. Biol. Chem. 285, 20428-20432
8. Seredenina, T., Gokce, O., and Luthi-Carter, R. (2011) Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One 6, e22231
9. Lu, B., and Palacino, J. (2013) A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J. 27, 1820-1829
10. Mealer, R. G., Subramaniam, S., and Snyder, S. H. (2013) Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease. J. Neurosci. 33, 4206-4210
11. Baiamonte, B. A., Lee, F. A., Brewer, S. T., Spano, D., and LaHoste, G. J. (2013) Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease. PLoS One 8, e53606
12. Banerjee, R., Beal, M. F., and Thomas, B. (2010) Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 33, 541-549
13. Salminen, A., and Kaarniranta, K. (2009) Regulation of the aging process by autophagy. Trends Mol. Med. 15, 217-224
14. Rubinsztein, D. C., Mariño, G., and Kroemer, G. (2011) Autophagy and aging. Cell 146, 682-695
15. Sarkar, S., and Rubinsztein, D. C. (2008) Huntington's disease: degradation of mutant huntingtin by autophagy. FEBS J. 275, 4263-4270
16. Renna, M., Jimenez-Sanchez, M., Sarkar, S., and Rubinsztein, D. C. (2010) Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J. Biol. Chem. 285, 11061-11067
17. Harris, H., and Rubinsztein, D. C. (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108-117
18. Jimenez-Sanchez, M., Thomson, F., Zavodszky, E., and Rubinsztein, D. C. (2012) Autophagy and polyglutamine diseases. Prog. Neurobiol. 97, 67-82
19. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D., and Cuervo, A. M. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13, 567-576
20. Nagata, E., Sawa, A., Ross, C. A., and Snyder, S. H. (2004) Autophagosomelike vacuole formation in Huntington's disease lymphoblasts. Neuroreport. 15, 1325-1328
21. Zheng, S., Clabough, E. B., Sarkar, S., Futter, M., Rubinsztein, D. C., and Zeitlin, S. O. (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet. 6, e1000838
22. Yang, Z., and Klionsky, D. J. (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124-131
23. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
24. Subramaniam, S., Napolitano, F., Mealer, R. G., Kim, S., Errico, F., Barrow, R., Shahani, N., Tyagi, R., Snyder, S. H., and Usiello, A. (2011) Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPAinduced dyskinesia. Nat. Neurosci. 15, 191-193
25. Santini, E., Heiman, M., Greengard, P., Valjent, E., and Fisone, G. (2009) Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPAinduced dyskinesia. Sci. Signal 2, ra36
26. Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., and Rubinsztein, D. C. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595
27. Sun, Q., Fan, W., Chen, K., Ding, X., Chen, S., and Zhong, Q. (2008) Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 105, 19211-19216
28. Mizushima, N., Yoshimori, T., and Levine, B. (2010) Methods in mammalian autophagy research. Cell 140, 313-326
29. Vargiu, P., De Abajo, R., Garcia-Ranea, J. A., Valencia, A., Santisteban, P., Crespo, P., and Bernal, J. (2004) The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23, 559-568
30. Sinha, S., and Levine, B. (2008) The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 27, S137-148
31. Kang, R., Zeh, H. J., Lotze, M. T., and Tang, D. (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18, 571-580
32. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., and Levine, B. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939
33. Wei, Y., Pattingre, S., Sinha, S., Bassik, M., and Levine, B. (2008) JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678-688
34. Bodemann, B. O., Orvedahl, A., Cheng, T., Ram, R. R., Ou, Y. H., Formstecher, E., Maiti, M., Hazelett, C. C., Wauson, E. M., Balakireva, M., Camonis, J. H., Yeaman, C., Levine, B., and White, M. A. (2011) RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 144, 253-267
35. Guo, J. Y., Chen, H. Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., Kamphorst, J. J., Chen, G., Lemons, J. M., Karantza, V., Coller, H. A., Dipaola, R. S., Gelinas, C., Rabinowitz, J. D., and White, E. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470
36. Elgendy, M., Sheridan, C., Brumatti, G., and Martin, S. J. (2011) Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 42, 23-35
37. Yamamoto, A., Cremona, M. L., and Rothman, J. E. (2006) Autophagymediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol. 172, 719-731
38. Shibata, M., Lu, T., Furuya, T., Degterev, A., Mizushima, N., Yoshimori, T., MacDonald, M., Yankner, B., and Yuan, J. (2006) Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 281, 14474-14485
39. Harrison, L. M., Muller, S. H., and Spano, D. (2013) Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum. Neuroscience 236, 21-30
40. Bang, S., Steenstra, C., and Kim, S. F. (2012) Striatum specific protein, Rhes regulates AKT pathway. Neurosci. Lett. 521, 142-147
41. Sbodio, J. I., Paul, B. D., Machamer, C. E., and Snyder, S. H. (2013) Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease. Cell Rep. 4, 890-897
42. Choi, B. R., Bang, S., Chen, Y., Cheah, J. H., and Kim, S. F. (2013) PKA modulates iron trafficking in the striatum via small GTPase, Rhes. Neuroscience 253, 214-220
43. Li, X. J., and Li, S. (2011) Proteasomal dysfunction in aging and Huntington disease. Neurobiol. Dis. 43, 4-8
44. Subramaniam, S., and Snyder, S. H. (2011) Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum). Neuropharmacology 60, 1187-1192